loading page

Effect of 5-HT3 serotonergic receptor blockade on the evaluation of thermal, mechanical pain thresholds and conditioned pain modulation in humans.
  • +1
  • Bruno Vítor Santiago,
  • Bruno Parada,
  • Maud Parise,
  • Nivaldo Villela
Bruno Vítor Santiago
State University of Rio de Janeiro Biomedical Centre
Author Profile
Bruno Parada
Rio de Janeiro State University
Author Profile
Maud Parise
Rio de Janeiro State University
Author Profile
Nivaldo Villela
Rio de Janeiro State University
Author Profile

Abstract

One form known as pain modulation is the phenomenon of inhibiting pain using a prior pain stimulus. The term CPM (conditioned pain modulation) is used to describe this phenomenon in humans. Serotonin pathways work as both anti- and pro-nociceptive pathways. Ondansetron is a 5HT3 receptor antagonist routinely used to prevent postoperative nausea and vomiting. Therefore, this study’s objective was to evaluate ondansetron’s effect on mechanical and thermal pain thresholds, as well as CPM in humans. 17 volunteers, who were randomly selected and double-blinded, participated in the research. They received an intravenous solution containing 1 - NaCl at 0.9%, in a volume of 20 mL; 2 - NaCl at 0.9% and 8 mg ondansetron in a volume of 20 mL. Using the quantitative sensory test (QST), we obtained the thresholds for detecting warm and cold; pain thresholds to hot and cold; the pressure pain threshold. CPM was evaluated using the parallel paradigm in which two identical nociceptive test stimuli were induced before and simultaneous to a conditioned nociceptive stimulus. Thirty minutes after the intervention, we redid the tests. We repeated the tests one week later but using the different solution so that each participant was their own control (crossover). We used the Wilcoxon test to compare the variables. Ondansetron, intravenously, improved CPM (p<0.05) and influenced thermal detection thresholds (heat and cold p < 0.05). There is evidence that the results related to the antagonism of the 5HT-3 receptor by ondansetron, occur through inhibition of facilitating descending pathways, improving the CPM.